Unveiling potential inhibitors targeting the nucleocapsid protein of SARS-CoV-2: Structural insights into their binding sites
Authors:
- 15 June 2024
- journal article
- research article
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 273 (Pt 2) , 133167
Abstract
No abstract availableKeywords
Funding Information
- Department of Atomic Energy, Government of India
This publication has 36 references indexed in Scilit:
- Transcription coupled DNA repair protein UVSSA binds to DNA and RNA: Mapping of nucleic acid interaction sites on human UVSSAArchives of Biochemistry and Biophysics, 2023
- UCSF ChimeraX: Structure visualization for researchers, educators, and developersProtein Science, 2020
- Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sitesActa Pharmaceutica Sinica B, 2020
- Biochemical characterization of SARS-CoV-2 nucleocapsid proteinBiochemical and Biophysical Research Communications, 2020
- Ceftazidime-Avibactam: A Review in the Treatment of Serious Gram-Negative Bacterial InfectionsDrugs, 2018
- Performance of HADDOCK and a simple contact-based protein–ligand binding affinity predictor in the D3R Grand Challenge 2Journal of Computer-Aided Molecular Design, 2017
- SARS-CoV nucleocapsid protein antagonizes IFN-β response by targeting initial step of IFN-β induction pathway, and its C-terminal region is critical for the antagonismVirus Genes, 2010
- High Throughput Production of Recombinant Human Proteins for Crystallography2008
- The nucleocapsid protein of the SARS coronavirus is capable of self-association through a C-terminal 209 amino acid interaction domainBiochemical and Biophysical Research Communications, 2004
- NMRPipe: A multidimensional spectral processing system based on UNIX pipesJournal of Biomolecular NMR, 1995